Virus meets host MicroRNA: The destroyer, the Booster, the Hijacker

Molecular and Cellular Biology

Volumn 34, Issue 20, 2014, Pages 3780-3787

  Guo, Yang Eric ^a,b   Steitz, Joan A ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 122; MICRORNA 138; MICRORNA 142; MICRORNA 155; MICRORNA 200; UNCLASSIFIED DRUG;

BASE PAIRING; CELL TYPE; CYTOMEGALOVIRUS; DEGRADATION; EASTERN EQUINE ENCEPHALOMYELITIS VIRUS; EPSTEIN BARR VIRUS; GENE EXPRESSION REGULATION; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS 1; HERPES VIRUS SAIMIRI; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 8; LIFE CYCLE; MARDIVIRUS; NONHUMAN; SHORT SURVEY; SIMIAN FOAMY VIRUS; UPREGULATION; VIRUS CELL INTERACTION; VIRUS REPLICATION; ANIMAL; GENETICS; HERPES VIRUS; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; POXVIRUS; REVIEW; RNA INTERFERENCE; RNA STABILITY;

ANIMALS; BASE SEQUENCE; ENCEPHALITIS VIRUS, EASTERN EQUINE; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRIDAE; HOST-PATHOGEN INTERACTIONS; HUMANS; MICRORNAS; POXVIRIDAE; RNA INTERFERENCE; RNA STABILITY;

EID: 84907148686     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00871-14     Document Type: Short Survey

References (83)

1. DiMaio D. 2012. Viruses, masters at downsizing. Cell Host Microbe 11: 560-561. http://dx.doi.org/10.1016/j.chom.2012.05.004.
2. Philippe N, Legendre M, Doutre G, Coute Y, Poirot O, Lescot M, Arslan D, Seltzer V, Bertaux L, Bruley C, Garin J, Claverie JM, Abergel C. 2013. Pandoraviruses: amoeba viruses with genomes up to 2.5 Mb reaching that of parasitic eukaryotes. Science 341:281-286. http://dx.doi .org/10.1126/science.1239181.
3. La Scola B, Audic S, Robert C, Jungang L, de Lamballerie X, Drancourt M, Birtles R, Claverie JM, Raoult D. 2003. A giant virus in amoebae. Science 299:2033. http://dx.doi.org/10.1126/science.1081867.
4. Raoult D, Audic S, Robert C, Abergel C, Renesto P, Ogata H, La Scola B, Suzan M, Claverie JM. 2004. The 1.2-megabase genome sequence of mimivirus. Science 306:1344-1350. http://dx.doi.org/10.1126/science .1101485.
5. Fields BN, Knipe DM, Howley PM. 2007. Fields virology, 5th ed. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, PA.
6. Lander ES. 2011. Initial impact of the sequencing of the human genome. Nature 470:187-197. http://dx.doi.org/10.1038/nature09792.
7. Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136:215-233. http://dx.doi.org/10.1016/j.cell.2009.01.002.
8. Brodersen P, Voinnet O. 2009. Revisiting the principles of microRNA target recognition and mode of action. Nat. Rev. Mol. Cell Biol. 10:141- 148. http://dx.doi.org/10.1038/nrm2619.
9. Chi SW, Hannon GJ, Darnell RB. 2012. An alternative mode of microRNA target recognition. Nat. Struct. Mol. Biol. 19:321-327. http://dx .doi.org/10.1038/nsmb.2230.
10. Hobert O. 2008. Gene regulation by transcription factors and microRNAs. Science 319:1785-1786. http://dx.doi.org/10.1126/science.1151651.
11. Ebert MS, Sharp PA. 2012. Roles for microRNAs in conferring robustness to biological processes. Cell 149:515-524. http://dx.doi.org/10.1016/j.cell.2012.04.005.
12. Ensser A, Fleckenstein B. 2005. T-cell transformation and oncogenesis by gamma2-herpesviruses. Adv. Cancer Res. 93:91-128. http://dx.doi.org/10.1016/S0065-230X(05)93003-0.
13. Lee SI, Murthy SC, Trimble JJ, Desrosiers RC, Steitz JA. 1988. Four novel U RNAs are encoded by a herpesvirus. Cell 54:599-607. http://dx.doi.org/10.1016/S0092-8674(88)80004-7.
14. Wassarman DA, Lee SI, Steitz JA. 1989. Nucleotide sequence of HSUR 5 RNA from herpesvirus saimiri. Nucleic Acids Res. 17:1258. http://dx.doi .org/10.1093/nar/17.3.1258.
15. Albrecht JC, Fleckenstein B. 1992. Nucleotide sequence of HSUR 6 and HSUR 7, two small RNAs of herpesvirus saimiri. Nucleic Acids Res. 20: 1810. http://dx.doi.org/10.1093/nar/20.7.1810.
16. Cazalla D, Yario T, Steitz JA. 2010. Down-regulation of a host microRNA by a herpesvirus saimiri noncoding RNA. Science 328:1563- 1566. http://dx.doi.org/10.1126/science.1187197.
17. Chi SW, Zang JB, Mele A, Darnell RB. 2009. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460:479-486. http: //dx.doi.org/10.1038/nature08170.
18. Guo YE, Riley KJ, Iwasaki A, Steitz JA. 2014. Alternative capture of noncoding RNAs or protein-coding genes by herpesviruses to alter host T cell function. Mol. Cell 54:67-79. http://dx.doi.org/10.1016/j.molcel.2014.03.025.
19. Cook HL, Lytle JR, Mischo HE, Li MJ, Rossi JJ, Silva DP, Desrosiers RC, Steitz JA. 2005. Small nuclear RNAs encoded by Herpesvirus saimiri upregulate the expression of genes linked to T cell activation in virally transformed T cells. Curr. Biol. 15:974-979. http://dx.doi.org/10.1016/j.cub.2005.04.034.
20. Buck AH, Perot J, Chisholm MA, Kumar DS, Tuddenham L, Cognat V, Marcinowski L, Dolken L, Pfeffer S. 2010. transcriptional regulation of miR-27 in murine cytomegalovirus infection. RNA 16:307-315. http://dx .doi.org/10.1261/rna.1819210.
21. Libri V, Helwak A, Miesen P, Santhakumar D, Borger JG, Kudla G, Grey F, Tollervey D, Buck AH. 2012. Murine cytomegalovirus encodes a miR-27 inhibitor disguised as a target. Proc. Natl. Acad. Sci. U. S. A. 109:279-284. http://dx.doi.org/10.1073/pnas.1114204109.
22. Marcinowski L, Tanguy M, Krmpotic A, Radle B, Lisnic VJ, Tuddenham L, Chane-Woon-Ming B, Ruzsics Z, Erhard F, Benkartek C, Babic M, Zimmer R, Trgovcich J, Koszinowski UH, Jonjic S, Pfeffer S, Dolken L. 2012. Degradation of cellular mir-27 by a novel, highly abundant viral transcript is important for efficient virus replication in vivo. PLoS Pathog. 8:e1002510. http://dx.doi.org/10.1371/journal.ppat.1002510.
23. Ameres SL, Horwich MD, Hung JH, Xu J, Ghildiyal M, Weng Z, Zamore PD. 2010. Target RNA-directed trimming and tailing of small silencing RNAs. Science 328:1534 -1539. http://dx.doi.org/10.1126 /science.1187058.
24. Hsu KM, Pratt JR, Akers WJ, Achilefu SI, Yokoyama WM. 2009. Murine cytomegalovirus displays selective infection of cells within hours after systemic administration. J. Gen. Virol. 90:33-43. http://dx.doi.org /10.1099/vir.0.006668-0.
25. Slobedman B, Barry PA, Spencer JV, Avdic S, Abendroth A. 2009. Virus-encoded homologs of cellular interleukin-10 and their control of host immune function. J. Virol. 83:9618-9629. http://dx.doi.org/10.1128/JVI.01098-09.
26. Lee S, Song J, Kim S, Kim J, Hong Y, Kim Y, Kim D, Baek D, Ahn K. 2013. Selective degradation of host MicroRNAs by an intergenic HCMV noncoding RNA accelerates virus production. Cell Host Microbe 13:678- 690. http://dx.doi.org/10.1016/j.chom.2013.05.007.
27. Mendell JT. 2008. miRiad roles for the miR-17-92 cluster in development and disease. Cell 133:217-222. http://dx.doi.org/10.1016/j.cell.2008.04 .001.
28. Olive V, Jiang I, He L. 2010. mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int. J. Biochem. Cell Biol. 42:1348-1354. http://dx .doi.org/10.1016/j.biocel.2010.03.004.
29. Backes S, Shapiro JS, Sabin LR, Pham AM, Reyes I, Moss B, Cherry S, ten Oever BR. 2012. Degradation of host microRNAs by poxvirus poly(A) polymerase reveals terminal RNA methylation as a protective antiviral mechanism. Cell Host Microbe 12:200-210. http://dx.doi.org/10.1016/j .chom.2012.05.019.
30. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. 2005. MicroRNA expression profiles classify human cancers. Nature 435:834 - 838. http://dx.doi.org/10.1038/nature03702.
31. Yin Q, McBride J, Fewell C, Lacey M, Wang X, Lin Z, Cameron J, Flemington EK. 2008. MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J. Virol. 82:5295-5306. http://dx.doi.org/10.1128/JVI.02380-07.
32. Lu F, Weidmer A, Liu CG, Volinia S, Croce CM, Lieberman PM. 2008. Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. J. Virol. 82:10436-10443. http://dx.doi .org/10.1128/JVI.00752-08.
33. Linnstaedt SD, Gottwein E, Skalsky RL, Luftig MA, Cullen BR. 2010. Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J. Virol. 84:11670-11678. http://dx.doi.org/10.1128/JVI.01248-10.
34. Tam W, Ben-Yehuda D, Hayward WS. 1997. bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Mol. Cell. Biol. 17:1490-1502.
35. Haasch D, Chen YW, Reilly RM, Chiou XG, Koterski S, Smith ML, Kroeger P, McWeeny K, Halbert DN, Mollison KW, Djuric SW, Trevillyan JM. 2002. T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. Cell. Immunol. 217:78-86. http://dx.doi.org/10.1016/S0008-8749(02)00506-3.
36. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. 2007. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. U. S. A. 104:1604-1609. http://dx.doi.org /10.1073/pnas.0610731104.
37. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, Murphy A, Frendewey D, Valenzuela D, Kutok JL, Schmidt-Supprian M, Rajewsky N, Yancopoulos G, Rao A, Rajewsky K. 2007. Regulation of the germinal center response by microRNA-155. Science 316:604-608. http://dx.doi .org/10.1126/science.1141229.
38. Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N, Croce CM. 2006. Pre-B cell proliferation and lymphoblastic leukemia/highgrade lymphoma in E(mu)-miR155 transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 103:7024-7029. http://dx.doi.org/10.1073/pnas.0602266103.
39. O'Connell RM, Rao DS, Chaudhuri AA, Boldin MP, Taganov KD, Nicoll J, Paquette RL, Baltimore D. 2008. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J. Exp. Med. 205:585-594. http://dx.doi.org/10.1084/jem .20072108.
40. Loeb GB, Khan AA, Canner D, Hiatt JB, Shendure J, Darnell RB, Leslie CS, Rudensky AY. 2012. Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting. Molecular Cell 48: 760-770. http://dx.doi.org/10.1016/j.molcel.2012.10.002.
41. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. 2008. Widespread changes in protein synthesis induced by microRNAs. Nature 455:58-63. http://dx.doi.org/10.1038/nature07228.
42. Xu G, Fewell C, Taylor C, Deng N, Hedges D, Wang X, Zhang K, Lacey M, Zhang H, Yin Q, Cameron J, Lin Z, Zhu D, Flemington EK. 2010. Transcriptome and targetome analysis in MIR155 expressing cells using RNA-seq. RNA 16:1610-1622. http://dx.doi.org/10.1261/rna.2194910.
43. Skalsky RL, Cullen BR. 2010. Viruses, microRNAs, and host interactions. Annu. Rev. Microbiol. 64:123-141. http://dx.doi.org/10.1146/annurev .micro.112408.134243.
44. Zhu Y, Haecker I, Yang Y, Gao SJ, Renne R. 2013. gamma-Herpesvirusencoded miRNAs and their roles in viral biology and pathogenesis. Curr. Opin. Virol. 3:266-275. http://dx.doi.org/10.1016/j.coviro.2013.05.013.
45. Nair V, Zavolan M. 2006. Virus-encoded microRNAs: novel regulators of gene expression. Trends Microbiol. 14:169-175. http://dx.doi.org/10.1016/j.tim.2006.02.007.
46. Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, Chi JT, Braich R, Manoharan M, Soutschek J, Ohler U, Cullen BR. 2007. A viral microRNA functions as an orthologue of cellular miR-155. Nature 450: 1096-1099. http://dx.doi.org/10.1038/nature05992.
47. Skalsky RL, Samols MA, Plaisance KB, Boss IW, Riva A, Lopez MC, Baker HV, Renne R. 2007. Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J. Virol. 81:12836-12845. http://dx.doi.org /10.1128/JVI.01804-07.
48. Gottwein E, Corcoran DL, Mukherjee N, Skalsky RL, Hafner M, Nusbaum JD, Shamulailatpam P, Love CL, Dave SS, Tuschl T, Ohler U, Cullen BR. 2011. Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe 10:515-526. http://dx .doi.org/10.1016/j.chom.2011.09.012.
49. Haecker I, Gay LA, Yang Y, Hu J, Morse AM, McIntyre LM, Renne R. 2012. Ago HITS-CLIP expands understanding of Kaposi's sarcomaassociated herpesvirus miRNA function in primary effusion lymphomas. PLoS Pathog. 8:e1002884. http://dx.doi.org/10.1371/journal.ppat .1002884.
50. Manzano M, Shamulailatpam P, Raja AN, Gottwein E. 2013. Kaposi's sarcoma-associated herpesvirus encodes a mimic of cellular miR-23. J. Virol. 87:11821-11830. http://dx.doi.org/10.1128/JVI.01692-13.
51. Osterrieder N, Kamil JP, Schumacher D, Tischer BK, Trapp S. 2006. Marek's disease virus: from miasma to model. Nat. Rev. Microbiol. 4:283- 294. http://dx.doi.org/10.1038/nrmicro1382.
52. Morgan R, Anderson A, Bernberg E, Kamboj S, Huang E, Lagasse G, Isaacs G, Parcells M, Meyers BC, Green PJ, Burnside J. 2008. Sequence conservation and differential expression of Marek's disease virus microRNAs. J. Virol. 82:12213-12220. http://dx.doi.org/10.1128/JVI.01722-08.
53. Zhao Y, Xu H, Yao Y, Smith LP, Kgosana L, Green J, Petherbridge L, Baigent SJ, Nair V. 2011. Critical role of the virus-encoded microRNA-155 ortholog in the induction of Marek's disease lymphomas. PLoS Pathog. 7:e1001305. http://dx.doi.org/10.1371/journal.ppat.1001305.
54. Kincaid RP, Chen Y, Cox JE, Rethwilm A, Sullivan CS. 2014. Noncanonical microRNA (miRNA) biogenesis gives rise to retroviral mimics of lymphoproliferative and immunosuppressive host miRNAs. mBio 5:e00074 -14. http://dx.doi.org/10.1128/mBio.00074-14.
55. Kincaid RP, Burke JM, Sullivan CS. 2012. RNA virus microRNA that mimics a B-cell oncomiR. Proc. Natl. Acad. Sci. U. S. A. 109:3077-3082. http://dx.doi.org/10.1073/pnas.1116107109.
56. Chang J, Nicolas E, Marks D, Sander C, Lerro A, Buendia MA, Xu C, Mason WS, Moloshok T, Bort R, Zaret KS, Taylor JM. 2004. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol. 1:106-113. http://dx.doi.org/10.4161/rna.1.2.1066.
57. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. 2005. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438:685-689. http://dx.doi.org/10.1038/nature04303.
58. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R, Subramaniam A, Propp S, Lollo BA, Freier S, Bennett CF, Bhanot S, Monia BP. 2006. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metabol. 3:87-98. http://dx.doi.org/10.1016/j.cmet.2006.01.005.
59. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. 2005. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309:1577-1581. http://dx.doi.org/10.1126/science.1113329.
60. Jopling CL, Schutz S, Sarnow P. 2008. Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe 4:77-85. http://dx.doi.org/10.1016/j.chom.2008.05.013.
61. Fukuhara T, Kambara H, Shiokawa M, Ono C, Katoh H, Morita E, Okuzaki D, Maehara Y, Koike K, Matsuura Y. 2012. Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus. J. Virol. 86:7918-7933. http://dx .doi.org/10.1128/JVI.00567-12.
62. Kambara H, Fukuhara T, Shiokawa M, Ono C, Ohara Y, Kamitani W, Matsuura Y. 2012. Establishment of a novel permissive cell line for the propagation of hepatitis C virus by expression of microRNA miR122. J. Virol. 86:1382-1393. http://dx.doi.org/10.1128/JVI.06242-11.
63. Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, Kauppinen S, Orum H. 2010. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327:198-201. http://dx.doi.org/10.1126/science.1178178.
64. Boutell C, Everett RD. 2013. Regulation of alphaherpesvirus infections by the ICP0 family of proteins. J. Gen. Virol. 94:465-481. http://dx.doi.org/10.1099/vir.0.048900-0.
65. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, Lin C, Socci ND, Hermida L, Fulci V, Chiaretti S, Foa R, Schliwka J, Fuchs U, Novosel A, Muller RU, Schermer B, Bissels U, Inman J, Phan Q, Chien M, Weir DB, Choksi R, De Vita G, Frezzetti D, Trompeter HI, Hornung V, Teng G, Hartmann G, Palkovits M, Di Lauro R, Wernet P, Macino G, Rogler CE, Nagle JW, Ju J, Papavasiliou FN, Benzing T, Lichter P, Tam W, Brownstein MJ, Bosio A, Borkhardt A, Russo JJ, Sander C, Zavolan M, Tuschl T. 2007. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129:1401-1414. http://dx.doi.org/10.1016/j.cell.2007.04 .040.
66. Siegel G, Obernosterer G, Fiore R, Oehmen M, Bicker S, Christensen M, Khudayberdiev S, Leuschner PF, Busch CJ, Kane C, Hubel K, Dekker F, Hedberg C, Rengarajan B, Drepper C, Waldmann H, Kauppinen S, Greenberg ME, Draguhn A, Rehmsmeier M, Martinez J, Schratt GM. 2009. A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nat. Cell Biol. 11:705-716. http://dx.doi.org/10.1038/ncb1876
67. Pan D, Flores O, Umbach JL, Pesola JM, Bentley P, Rosato PC, Leib DA, Cullen BR, Coen DM. 2014. A neuron-specific host microRNA targets herpes simplex virus-1 ICP0 expression and promotes latency. Cell Host Microbe 15:446-456. http://dx.doi.org/10.1016/j.chom.2014.03 .004.
68. O'Connor CM, Vanicek J, Murphy EA. 2014. Host microRNA regulation of human cytomegalovirus immediate early protein translation promotes viral latency. J. Virol. 88:5524 -5532. http://dx.doi.org/10.1128/JVI.00481-14.
69. Riley KJ, Rabinowitz GS, Yario TA, Luna JM, Darnell RB, Steitz JA. 2012. EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J. 31:2207-2221. http://dxdoi.org/10.1038/emboj.2012.63.
70. Lu X, Li X, He Q, Gao J, Gao Y, Liu B, Liu F. 2013. miR-142-3p regulates the formation and differentiation of hematopoietic stem cells in vertebrates. Cell Res. 23:1356-1368. http://dx.doi.org/10.1038/cr.2013.145.
71. Nimmo R, Ciau-Uitz A, Ruiz-Herguido C, Soneji S, Bigas A, Patient R, Enver T. 2013. miR-142-3p controls the specification of definitive hemangioblasts during ontogeny. Dev. Cell 26:237-249. http://dx.doi.org/10.1016/j.devcel.2013.06.023.
72. Sonda N, Simonato F, Peranzoni E, Cali B, Bortoluzzi S, Bisognin A, Wang E, Marincola FM, Naldini L, Gentner B, Trautwein C, Sackett SD, Zanovello P, Molon B, Bronte V. 2013. miR-142-3p prevents macrophage differentiation during cancer-induced myelopoiesis. Immunity 38:1236-1249. http://dx.doi.org/10.1016/j.immuni.2013.06.004.
73. Carraro G, Shrestha A, Rostkovius J, Contreras A, Chao CM, El Agha E, Mackenzie B, Dilai S, Guidolin D, Taketo MM, Gunther A, Kumar ME, Seeger W, De Langhe S, Barreto G, Bellusci S. 2014. miR-142-3p balances proliferation and differentiation of mesenchymal cells during lung development. Development 141:1272-1281. http://dx.doi.org/10.1242/dev.105908.
74. Zhou Q, Haupt S, Prots I, Thummler K, Kremmer E, Lipsky PE, Schulze-Koops H, Skapenko A. 2013. miR-142-3p is involved in CD25_ CD4 T cell proliferation by targeting the expression of glycoprotein A repetitions predominant. J. Immunol. 190:6579-6588. http://dx.doi.org/10.4049/jimmunol.1202993.
75. Liu J, Li W, Wang S, Wu Y, Li Z, Wang W, Liu R, Ou J, Zhang C, Wang S. 2014. miR-142-3p attenuates the migration of CD4(+) T cells through regulating actin cytoskeleton via RAC1 and ROCK2 in arteriosclerosis obliterans. PLoS One 9:e95514. http://dx.doi.org/10.1371/journal.pone.0095514.
76. Trobaugh DW, Gardner CL, Sun C, Haddow AD, Wang E, Chapnik E, Mildner A, Weaver SC, Ryman KD, Klimstra WB. 2014. RNA viruses can hijack vertebrate microRNAs to suppress innate immunity. Nature 506:245-248. http://dx.doi.org/10.1038/nature12869.
77. Langlois RA, Varble A, Chua MA, Garcia-Sastre A, ten Oever BR. 2012. Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses. Proc. Natl. Acad. Sci. U. S. A. 109:12117-12122. http://dx.doi.org/10.1073/pnas.1206039109.
78. Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, Himber C, Saib A, Voinnet O. 2005. A cellular microRNA mediates antiviral defense in human cells. Science 308:557-560. http://dx.doi.org/10.1126/science.1108784.
79. Otsuka M, Jing Q, Georgel P, New L, Chen J, Mols J, Kang YJ, Jiang Z, Du X, Cook R, Das SC, Pattnaik AK, Beutler B, Han J. 2007. Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Immunity 27:123- 134. http://dx.doi.org/10.1016/j.immuni.2007.05.014.
80. Nathans R, Chu CY, Serquina AK, Lu CC, Cao H, Rana TM. 2009. Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol. Cell 34:696-709. http://dx.doi.org/10.1016/j.molcel.2009.06.003.
81. Gunasekharan V, Laimins LA. 2013. Human papillomaviruses modulate microRNA 145 expression to directly control genome amplification. J. Virol. 87:6037-6043. http://dx.doi.org/10.1128/JVI.00153-13.
82. Backes S, Langlois RA, Schmid S, Varble A, Shim JV, Sachs D, ten Oever BR. 2014. The Mammalian Response to Virus Infection Is Independent of Small RNA Silencing. Cell Rep. 8:114-125. http://dx.doi.org/10.1016/j.celrep.2014.05.038.
83. Bogerd HP, Skalsky RL, Kennedy EM, Furuse Y, Whisnant AW, Flores O, Schultz KL, Putnam N, Barrows NJ, Sherry B, Scholle F, Garcia-Blanco MA, Griffin DE, Cullen BR. 2014. Replication of many human viruses is refractory to inhibition by endogenous cellular microRNAs. J. Virol. 88:8065-8076. http://dx.doi.org/10.1128/JVI.00985-14.